Fred Hassan
Former chairman and CEO of Schering-Plough and Pharmacia, Fred Hassan is chairman of Caret Group. He also serves on the boards of Amgen and Intrexon.
Modern Bioscience Has Risen To The Challenge. Now It’s Our Turn.
For new vaccines to reach maximum efficacy, people have to actually take it—and surveys show confidence and trust are at an all-time low. CEOs are in a position to make all the difference.
Fred Hassan: A Case for Calm In The Covid-19 Storm
Business leaders must keep the current coronavirus crisis in perspective, and avoid the urge to get 'bunkered in,' says Fred Hassan, CEO of Caret Group and former chief executive of the global pharmaceutical giant Schering–Plough.
Follow The Timeless Wisdom Of “The Rule Of Three”
Schering-Plough's former CEO Fred Hassan explains how to harness a million years of human evolution to bring clarity and order to your planning.
- Advertisement -
- Advertisement -
FEATURED CONTENT
New Poll: CEOs Find Challenges In Using Customer Data To Drive Innovation
Ability to harness and sort through data for meaningful insights remains a hurdle, many say. “The key is...finding what is actually relevant.”
SUBSCRIBE TO CHIEF EXECUTIVE
Sign Up to Receive Chief Executive Magazine
Chief Executive’s publications are designed to help CEOs do their jobs better and run their businesses more effectively. Subscribe here.
CEO CONFIDENCE INDEX
In Poll, Majority of CEOs Say Hybrid Work Is Here to Stay for 2022. Full Virtual? Not so Much
Almost all the CEOs we surveyed in May say they will work in at least partially hybrid mode for the rest of the year—versus just 7 percent who said they'd be fully remote.